CAD & Atherosclerosis
From the Journals
Even one head injury boosts all-cause mortality risk
The findings of a new study underscore the importance of preventing head injuries and of swift clinical intervention once a head injury occurs,...
From the Journals
More type 2 diabetes deaths from cancer than heart disease
In people with type 2 diabetes, cancer screening should get at least as much attention as CVD prevention.
From the Journals
High HDL-C levels linked to increased fracture risk
High levels of high-density lipoprotein cholesterol are associated with a higher risk for fracture among older adults, a cohort study suggests.
Feature
Canadian guidance recommends reducing alcohol consumption
Consuming no drinks per week has benefits.
From the Journals
PCSK9 inhibitors for severe COVID? Pilot trial signals of benefit
“PCSK9 inhibition may represent a novel therapeutic pathway in addition to currently recommended therapeutic approaches for severe COVID-19.”
Opinion
Geriatrician advises on use of vitamin D supplementation, lecanemab, and texting for her patients
There is growing awareness of the impact of social isolation on health outcomes, particularly among older adults.
From the Journals
Evolocumab’s LDL lowering surpassed inclisiran’s in ORION-3
Results from a crossover subgroup of 92 patients in ORION-3 documented evolocumab’s greater LDL-lowering efficacy, compared with inclisiran.
From the Journals
After PCI, 1-month beats 12-month DAPT in high-risk patients
When dual was replaced by single antiplatelet therapy 1 month after PCI in Japanese patients, bleeding risk declined.
Feature
Does EPA lower CV risk? REDUCE-IT revisited
A prescription product consisting of a “highly purified” form of the omega-3 acid eicosapentaenoic acid, was heralded in 2018 as ushering in “the...
From the Journals
PPI use in type 2 diabetes links with cardiovascular events
Prospective data from almost 20,000 people with type 2 diabetes show that proton pump inhibitor use is linked with significantly more...
From the Journals
LDL cholesterol triglycerides ‘robust’ ASCVD risk marker
A large dual-method Danish population study identified high LDL triglyceride levels as a risk marker for atherosclerotic cardiovascular disease....